2,121 Shares in Core Laboratories N.V. (CLB) Purchased by Park National Corp OH

Park National Corp OH purchased a new position in Core Laboratories N.V. (NYSE:CLB) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 2,121 shares of the oil and gas company’s stock, valued at approximately $209,000.

Other large investors also recently modified their holdings of the company. Goldman Sachs Group Inc. increased its holdings in shares of Core Laboratories N.V. by 156.2% in the 1st quarter. Goldman Sachs Group Inc. now owns 68,823 shares of the oil and gas company’s stock worth $7,951,000 after buying an additional 41,955 shares during the last quarter. Parsons Capital Management Inc. RI increased its holdings in shares of Core Laboratories N.V. by 15.4% in the 1st quarter. Parsons Capital Management Inc. RI now owns 10,436 shares of the oil and gas company’s stock worth $1,206,000 after buying an additional 1,394 shares during the last quarter. Morgan Stanley increased its holdings in shares of Core Laboratories N.V. by 17.5% in the 1st quarter. Morgan Stanley now owns 167,465 shares of the oil and gas company’s stock worth $19,346,000 after buying an additional 24,929 shares during the last quarter. Cue Financial Group Inc. increased its holdings in shares of Core Laboratories N.V. by 11.0% in the 2nd quarter. Cue Financial Group Inc. now owns 2,525 shares of the oil and gas company’s stock worth $256,000 after buying an additional 250 shares during the last quarter. Finally, State Street Corp increased its holdings in shares of Core Laboratories N.V. by 2.4% in the 1st quarter. State Street Corp now owns 542,972 shares of the oil and gas company’s stock worth $62,732,000 after buying an additional 12,850 shares during the last quarter.

Shares of Core Laboratories N.V. (NYSE CLB) traded down 1.05% during midday trading on Wednesday, reaching $93.26. 181,362 shares of the company’s stock were exchanged. The stock’s 50 day moving average is $94.60 and its 200-day moving average is $102.10. Core Laboratories N.V. has a 12-month low of $86.55 and a 12-month high of $125.83. The stock has a market cap of $4.12 billion, a PE ratio of 57.21 and a beta of 1.64.

Core Laboratories N.V. (NYSE:CLB) last posted its quarterly earnings data on Monday, July 24th. The oil and gas company reported $0.52 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.51 by $0.01. Core Laboratories N.V. had a net margin of 11.80% and a return on equity of 49.29%. The business had revenue of $163.90 million for the quarter, compared to analysts’ expectations of $168.23 million. During the same quarter in the previous year, the business posted $0.35 earnings per share. The business’s revenue was up 10.7% compared to the same quarter last year. On average, equities analysts expect that Core Laboratories N.V. will post $1.98 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, November 21st. Stockholders of record on Friday, October 20th will be issued a $0.55 dividend. This represents a $2.20 dividend on an annualized basis and a dividend yield of 2.33%. The ex-dividend date of this dividend is Thursday, October 19th. Core Laboratories N.V.’s payout ratio is presently 134.15%.

TRADEMARK VIOLATION NOTICE: This news story was originally published by Transcript Daily and is the property of of Transcript Daily. If you are reading this news story on another domain, it was stolen and republished in violation of US & international trademark and copyright laws. The correct version of this news story can be accessed at https://transcriptdaily.com/2017/10/18/2121-shares-in-core-laboratories-n-v-clb-purchased-by-park-national-corp-oh.html.

A number of equities analysts have recently commented on CLB shares. Zacks Investment Research lowered shares of Core Laboratories N.V. from a “hold” rating to a “sell” rating in a report on Tuesday, September 26th. Piper Jaffray Companies set a $97.00 target price on shares of Core Laboratories N.V. and gave the company a “hold” rating in a report on Wednesday, July 26th. ValuEngine raised shares of Core Laboratories N.V. from a “sell” rating to a “hold” rating in a report on Friday, August 4th. Citigroup Inc. reduced their target price on shares of Core Laboratories N.V. from $102.00 to $100.00 and set a “neutral” rating on the stock in a report on Wednesday, July 26th. Finally, Royal Bank Of Canada reaffirmed a “buy” rating and set a $115.00 target price on shares of Core Laboratories N.V. in a report on Friday, September 1st. Four analysts have rated the stock with a sell rating, eight have given a hold rating and five have issued a buy rating to the company. Core Laboratories N.V. currently has a consensus rating of “Hold” and an average target price of $110.91.

About Core Laboratories N.V.

Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples.

Institutional Ownership by Quarter for Core Laboratories N.V. (NYSE:CLB)

Receive News & Ratings for Core Laboratories N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories N.V. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply